Literature DB >> 26720832

Sacubitril-Valsartan for the Treatment of Heart Failure: Effectiveness and Value.

Daniel A Ollendorf1, Alexander T Sandhu2, Steven D Pearson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26720832     DOI： 10.1001/jamainternmed.2015.7661

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  9 in total

1.  Sacubitril/valsartan in everyday clinical practice: an observational study based on the experience of a heart failure clinic.

Authors:  Joana Cabral; Henrique Vasconcelos; Paulo Maia-Araújo; Emília Moreira; Manuel Campelo; Sandra Amorim; Alexandra Sousa; Brenda Moura; Roberto Pinto; Camila Dias; José Silva-Cardoso
Journal:  Cardiovasc Diagn Ther       Date:  2021-12

Review 2.  Economic Issues in Heart Failure in the United States.

Authors:  Paul A Heidenreich; Gregg C Fonarow; Yekaterina Opsha; Alexander T Sandhu; Nancy K Sweitzer; Haider J Warraich
Journal:  J Card Fail       Date:  2022-01-24       Impact factor: 6.592

3.  Relation of Household Income to Access and Adherence to Combination Sacubitril/Valsartan in Heart Failure: A Retrospective Analysis of Commercially Insured Patients.

Authors:  Amber E Johnson; Gretchen M Swabe; Daniel Addison; Utibe R Essien; Khadijah Breathett; LaPrincess C Brewer; Sula Mazimba; Selma F Mohammed; Jared W Magnani
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2022-05-13

4.  Value-Based Hypothesis Testing for Cardiac Device Clinical Trials: A Pathway for Accelerated Reimbursement Decisions.

Authors:  Donald E Cutlip; Daniel B Kramer
Journal:  Circ Cardiovasc Interv       Date:  2016-05       Impact factor: 6.546

5.  Adoption of Sacubitril/Valsartan for the Management of Patients With Heart Failure.

Authors:  Lindsey R Sangaralingham; S Jeson Sangaralingham; Nilay D Shah; Xiaoxi Yao; Shannon M Dunlay
Journal:  Circ Heart Fail       Date:  2018-02       Impact factor: 8.790

Review 6.  Decision making in advanced heart failure: bench, bedside, practice, and policy.

Authors:  Daniel D Matlock; William C McGuire; Molly Magid; Larry Allen
Journal:  Heart Fail Rev       Date:  2017-09       Impact factor: 4.214

Review 7.  Practical guidance on the use of sacubitril/valsartan for heart failure.

Authors:  Andrew J Sauer; Robert Cole; Brian C Jensen; Jay Pal; Nakul Sharma; Amin Yehya; Justin Vader
Journal:  Heart Fail Rev       Date:  2019-03       Impact factor: 4.214

Review 8.  Advanced Heart Failure and End-Stage Heart Failure: Does a Difference Exist.

Authors:  Paolo Severino; Paul J Mather; Mariateresa Pucci; Andrea D'Amato; Marco Valerio Mariani; Fabio Infusino; Lucia Ilaria Birtolo; Viviana Maestrini; Massimo Mancone; Francesco Fedele
Journal:  Diagnostics (Basel)       Date:  2019-11-01

9.  Evaluating Cost-Effectiveness Models for Pharmacologic Interventions in Adults with Heart Failure: A Systematic Literature Review.

Authors:  Gian Luca Di Tanna; Anna Bychenkova; Frank O'Neill; Heidi S Wirtz; Paul Miller; Briain Ó Hartaigh; Gary Globe
Journal:  Pharmacoeconomics       Date:  2019-03       Impact factor: 4.981
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.